BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 24426346)

  • 1. Acute promyelocytic leukemia presenting as ischemic stroke in young.
    Kapoor R; Pati HP; Gupta SK; Gupta N
    Indian J Hematol Blood Transfus; 2013 Jun; 29(2):93-5. PubMed ID: 24426346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transient ischemic attack as an unusual initial manifestation of acute promyelocytic leukemia.
    Liu L; Yuan X
    Int J Hematol; 2016 Jul; 104(1):134-8. PubMed ID: 26984593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case Report: ANXA2 Associated Life-Threatening Coagulopathy With Hyperfibrinolysis in a Patient With Non-APL Acute Myeloid Leukemia.
    Ruhnke L; Stölzel F; Wagenführ L; Altmann H; Platzbecker U; Herold S; Rump A; Schröck E; Bornhäuser M; Schetelig J; von Bonin M
    Front Oncol; 2021; 11():666014. PubMed ID: 33937079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in the management of coagulopathy in acute promyelocytic leukemia.
    Sanz MA; Montesinos P
    Thromb Res; 2020 Jul; 191 Suppl 1():S63-S67. PubMed ID: 32736781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of ischemic stroke in acute promyelocytic leukemia at initial presentation. Relevance of all-trans retinoic acid treatment.
    Carella AM; Antonucci G; Conte M; Di Pumpo M; Antonucci E; Ponziano E
    Cardiovasc Hematol Disord Drug Targets; 2010 Mar; 10(1):1-6. PubMed ID: 20041837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased promyelocytic-derived microparticles: a novel potential factor for coagulopathy in acute promyelocytic leukemia.
    Ma G; Liu F; Lv L; Gao Y; Su Y
    Ann Hematol; 2013 May; 92(5):645-52. PubMed ID: 23344645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Massive Pulmonary Embolism at the Onset of Acute Promyelocytic Leukemia.
    Sorà F; Chiusolo P; Laurenti L; Autore F; Giammarco S; Sica S
    Mediterr J Hematol Infect Dis; 2016; 8(1):e2016027. PubMed ID: 27413520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombosis in acute promyelocytic leukemia.
    Rashidi A; Silverberg ML; Conkling PR; Fisher SI
    Thromb Res; 2013 Apr; 131(4):281-9. PubMed ID: 23266518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute promyelocytic leukemia presenting with features of metastatic osseous disease.
    Winters C; Chen AI; Moore S; Traer E; Dunlap J
    Leuk Res Rep; 2018; 9():36-37. PubMed ID: 29892546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Open issues on bleeding and thrombosis in acute promyelocytic leukemia.
    Sanz MA; Montesinos P
    Thromb Res; 2010 Apr; 125 Suppl 2():S51-4. PubMed ID: 20434005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment of acute promyelocytic leukemia in a patient with prosthetic heart valves: a case report and review of the literature.
    Haghighat S; Rezvani A; Mokhtari M
    J Med Case Rep; 2021 May; 15(1):260. PubMed ID: 33941263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coagulopathy of acute promyelocytic leukemia.
    Falanga A; Barbui T
    Acta Haematol; 2001; 106(1-2):43-51. PubMed ID: 11549776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meeting report. Acute promyelocytic leukemia-associated coagulopathy, 21 January 2004, London, United Kingdom.
    Tallman MS; Brenner B; Serna Jde L; Dombret H; Falanga A; Kwaan HC; Liebman H; Raffoux E; Rickles FR
    Leuk Res; 2005 Mar; 29(3):347-51. PubMed ID: 15661272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue factor-bearing microparticles are a link between acute promyelocytic leukemia cells and coagulation activation: a human subject study.
    Zhao H; Sun J; Yan L; Jin B; Hou W; Cao F; Li H; Zhou J; Zhang Y
    Ann Hematol; 2021 Jun; 100(6):1473-1483. PubMed ID: 33893844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombomodulin alfa treatment in patients with acute promyelocytic leukemia and disseminated intravascular coagulation: a retrospective analysis of an open-label, multicenter, post-marketing surveillance study cohort.
    Matsushita T; Watanabe J; Honda G; Mimuro J; Takahashi H; Tsuji H; Eguchi Y; Kitajima I; Sakata Y
    Thromb Res; 2014 May; 133(5):772-81. PubMed ID: 24636871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA-DRneg patients without acute promyelocytic leukemia show distinct immunophenotypic, genetic, molecular, and cytomorphologic characteristics compared to acute promyelocytic leukemia.
    Oelschlaegel U; Mohr B; Schaich M; Schäkel U; Kroschinsky F; Illmer T; Ehninger G; Thiede C
    Cytometry B Clin Cytom; 2009 Sep; 76(5):321-7. PubMed ID: 19291801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis and treatment of thrombohemorrhagic diathesis in acute promyelocytic leukemia.
    Falanga A; Russo L; Tartari CJ
    Mediterr J Hematol Infect Dis; 2011; 3(1):e2011068. PubMed ID: 22220265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk Markers for Significant Bleeding and Thrombosis in Pediatric Acute Promyelocytic Leukemia; Report From the Children's Oncology Group Study AAML0631.
    Rajpurkar M; Alonzo TA; Wang YC; Gerbing RB; Gamis AS; Feusner JH; Gregory J; Kutny MA
    J Pediatr Hematol Oncol; 2019 Jan; 41(1):51-55. PubMed ID: 30095694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis and management of the bleeding diathesis in acute promyelocytic leukaemia.
    Falanga A; Rickles FR
    Best Pract Res Clin Haematol; 2003 Sep; 16(3):463-82. PubMed ID: 12935963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cryptic Acute Promyelocytic Leukemia (APL) Presenting as Seizures in an Adolescent.
    Mai B; Liang C; Nguyen A; Wahed A; Chen L
    Ann Clin Lab Sci; 2020 Mar; 50(2):270-273. PubMed ID: 32366568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.